ADM13 | ADAMTS13 Activity and Inhibitor Profile, Plasma

This test is intended for assisting with the diagnosis of congenital or acquired thrombotic thrombocytopenic purpura.

AMYR | Beta-Amyloid Ratio (1-42/1-40), Spinal Fluid

This test is intended for assisting in the evaluation of adult patients, aged 55 years and older, presenting with cognitive impairment and who are being assessed for Alzheimer disease and other causes of cognitive decline.

C5B9 | SC5b-9 Level Terminal Complement Complex, Plasma

This test is intended for detecting increased complement activation.

CLLDF | Chronic Lymphocytic Leukemia, Diagnostic FISH, Varies

This test is intended for detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with chronic lymphocytic leukemia (CLL).

CLLMF | Chronic Lymphocytic Leukemia, Specified FISH, Varies

This test is intended for detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with chronic lymphocytic leukemia (CLL).

CRSBF | Crystal Identification, Body Fluid

This test is intended for identifying the presence and type of crystals in synovial fluid.

LAPYP | Lactate Pyruvate Panel, Plasma

This test is intended for diagnosing and monitoring patients with lactic acidosis.

MMPP | Mitochondrial Metabolites, Plasma

This test is intended for monitoring patients with mitochondrial disorders, organic acidurias, and ketone body disorders.

OAPNS | Ova and Parasite, Microscopy, Varies

This test is intended for detection and identification of parasitic protozoa and the eggs and larvae of parasitic helminths.

RETB | Reticulocyte Profile, Blood

This test is intended for assessing erythropoietic bone marrow activity in anemia and other hematologic conditions.

UBLAS | Blastomyces Antigen, Quantitative, Enzyme Immunoassay, Random, Urine

This test is intended for diagnosis of infection with Blastomyces dermatitidis.

WESMT | Whole Exome and Mitochondrial Genome Sequencing, Varies

This test is intended for serving as a first-tier test to identify a molecular and/or mitochondrial diagnosis in patients with suspected genetic disorders.

WESR | Whole Exome Sequencing Reanalysis, Varies

This test is intended for identifying a diagnosis or additional variants associated with the phenotype in patients who previously have had a negative or inconclusive whole exome sequencing test.